Latest filing:
Bain Capital Life Sciences Investors, LLC files SEC Form 4 reports at RAPID MICRO BIOSYSTEMS, INC. (RPID). 6 SEC Form 4 filings on record going back to 2024, most recently on 22 May 2026. Most recent open-market trade: sold $1.69M of HTFL on 1 May 2026. Lifetime open-market purchases: $65.00M. Lifetime open-market sales: $115.00M.
The latest 10 SEC Form 4 transactions reported by Bain Capital Life Sciences Investors, LLC.
Insiders who reported open-market trades in the last 12 months at the companies Bain Capital Life Sciences Investors, LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Browse nearby insider profiles in alphabetical order.
Bain Capital Life Sciences Investors, LLC is an investment firm of RAPID MICRO BIOSYSTEMS, INC. (RPID). InsiderAlpha holds 6 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 22 May 2026, one of 6 filings going back to 2024.
Recorded transactions: 5 open-market purchases ($65.00M) and 5 open-market sales ($115.00M) across all tracked filings.
InsiderAlpha's records for Bain Capital Life Sciences Investors, LLC go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $32.50M (2 of 5 buys carry a usable dollar value, totaling $65.00M). The largest single buy on record is $40.00M of NAMS in 2024. Sales side: 5 recorded sales totaling $115.00M, so the filing history runs sell-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
